A Study to Evaluate ALN-AGT01 RVR in Adult Healthy Volunteers
Enrolling
The purpose of this study is to evaluate the safety, tolerability and PK of single
ascending doses of ALN-AGT01 RVR.
Trial at a Glance
- Trial ID
- ALN-AGT01 RVR-001
- Condition
- Healthy Volunteers
- Drug/Treatment
- Placebo, ALN-AGT01 RVR
- Does this trial use a placebo?
- Yes
- Trial Type
- Interventional
- Number of Participants
- 78 participants
- Trial dates
- November 5, 2024 - September 8, 2025
For more information:NCT06675565
Who can participate?
AGE
18 to 65 Years
SEX
All
ACCEPTS HEALTHY VOLUNTEERS?
Yes
Inquire about a clinical trial
Contact Alnylam directly with any questions about our clinical trials.
Inquire about a clinical trial
Contact Alnylam directly with any questions
about our clinical trials.
about our clinical trials.
